|
Q2 FY2023
As of Mar 31, 2023
|
Q1 FY2023
As of Dec 31, 2022
|
Q4 FY2022
As of Sep 30, 2022
|
Q3 FY2022
As of Jun 30, 2022
|
Q2 FY2022
As of Mar 31, 2022
|
Q1 FY2022
As of Dec 31, 2021
|
Q4 FY2021
As of Sep 30, 2021
|
Q3 FY2021
As of Jun 30, 2021
|
Q2 FY2021
As of Mar 31, 2021
|
Q1 FY2021
As of Dec 31, 2020
|
Q4 FY2020
As of Sep 30, 2020
|
Q3 FY2020
As of Jun 30, 2020
|
Q2 FY2020
As of Mar 31, 2020
|
Q1 FY2020
As of Dec 31, 2019
|
Q4 FY2019
As of Sep 30, 2019
|
Q3 FY2019
As of Jun 30, 2019
|
Q2 FY2019
As of Mar 31, 2019
|
Q1 FY2019
As of Dec 31, 2018
|
Q4 FY2018
As of Sep 30, 2018
|
Q3 FY2018
As of Jun 30, 2018
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Receivables, net | ||||||||||||||||||||
| Inventories, net | ||||||||||||||||||||
| Contract assets | ||||||||||||||||||||
| Prepaid and other current assets | ||||||||||||||||||||
| Income tax receivable | ||||||||||||||||||||
| Common Stock, Par or Stated Value Per Share | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Property, plant, and equipment, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Deferred income taxes, net of valuation allowance | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other non‑current assets | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Current portion of debt, net of deferred financing fees and discounts | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Product warranties | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Non‑current liabilities | ||||||||||||||||||||
| Long-term debt, net of deferred financing fees and discounts | ||||||||||||||||||||
| Obligation under operating leases | ||||||||||||||||||||
| Other non‑current liabilities | ||||||||||||||||||||
| Deferred income taxes | ||||||||||||||||||||
| Non-current liabilities held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity | ||||||||||||||||||||
| Common stock, par value $0.01: authorized 1,000,000 shares; issued 123,944 shares, outstanding 122,280 at March 31, 2023; issued 123,411 shares, outstanding 121,747 at September 30, 2022 | ||||||||||||||||||||
| Treasury stock: 1,664 shares at March 31, 2023 and 1,664 shares at September 30, 2022 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income, net of tax | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Non‑controlling interest | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
